References
  1. Roth DE, Abrams SA, Aloia J, Bergeron G, Bourassa MW, Brown KH, et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann N Y Acad Sci. 2018;1430:44-79.
  2. Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013;88:720-755. doi:10.1016/j.mayocp.2013.05.011.
  3. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res . 2011;26:2341-2357. doi:10.1002/jbmr.463.
  4. Ganguly A, Tamblyn JA, Finn-Sell S, Chan SY, Westwood M, Gupta J, et al. Vitamin D, the placenta and early pregnancy: effects on trophoblast function. J Endocrinol . 2018;236(2):R93-r103. doi:10.1530/JOE-17-0491.
  5. Kumar R, Cohen WR, Silva P, Epstein FH. Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J Clin Invest . 1979;63:342-344. 10.1172/jci109308
  6. Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D, Calcium: Dietary Reference Intakes for Calcium and Vitamin D. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, Eds. Washington (DC), National Academies Press (US). National Academy of Sciences, 2011
  7. Halhali A, Villa AR, Madrazo E, Soria MC, Mercado E, Diaz L, et al. Longitudinal changes in maternal serum 1,25-dihydroxyvitamin D and insulin like growth factor I levels in pregnant women who developed preeclampsia: comparison with normotensive pregnant women. J Steroid Biochem Mol Biol. 2004;89-90(1-5):553-556. 10.1016/j.jsbmb.2004.03.069
  8. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia.J Clin Endocrinol Metab 2007;92: 3517-3522. 10.1210/jc.2007-0718
  9. Robinson CJ, Alanis MC, Wagner CL, Hollis BW, Johnson DD. Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia.Am J Obstet Gynecol. 2010;203:366.e361-366. doi:10.1016/j.ajog.2010.06.036.
  10. Ma R, Gu Y, Zhao S, Sun J, Groome LJ, Wang Y. Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies. Am J Physiol Endocrinol Metab. 2012;303:E928-935. doi:10.1152/ajpendo.00279.2012.
  11. Wei SQ, Audibert F, Hidiroglou N, Sarafin K, Julien P, Wu Y, et al. Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. BJOG . 2012;119:832-839. doi:10.1111/j.1471-0528.2012.03307.x.
  12. Bodnar LM, Simhan HN, Catov JM, Roberts JM, Platt RW, Diesel JC, et al. Maternal vitamin D status and the risk of mild and severe preeclampsia. Epidemiology. 2014;25:207-214. doi:10.1097/EDE.0000000000000039.
  13. Smith TA, Kirkpatrick DR, Kovilam O, Agrawal DK. Immunomodulatory role of vitamin D in the pathogenesis of preeclampsia. Expert Rev Clin Immunol. 2015;11:1055-1063. doi:10.1586/1744666X.2015.1056780.
  14. Kiely ME, Zhang JY, Kinsella M, Khashan AS, Kenny LC. Vitamin D status is associated with uteroplacental dysfunction indicated by pre-eclampsia and small-for-gestational-age birth in a large prospective pregnancy cohort in Ireland with low vitamin D status.Am J Clin Nutr. 2016;104:354-361. doi:10.3945/ajcn.116.130419.
  15. Tamblyn JA, Susarla R, Jenkinson C, Jeffery LE, Ohizua O, Chun RF, et al. Dysregulation of maternal and placental vitamin D metabolism in preeclampsia. Placenta. 2017;50:70-77. doi:10.1016/j.placenta.2016.12.019.
  16. Vestgaard M, Secher AL, Ringholm L, Jensen JB, Damm P, Mathiesen ER. Vitamin D insufficiency, preterm delivery and preeclampsia in women with type 1 diabetes - an observational study. Acta Obstet Gynecol Scand . 2017;96:1197-1204. doi:10.1111/aogs.13180.
  17. Mirzakhani H, Carey VJ, McElrath TF, Laranjo N, O’Connor G, Iverson RE, et al. The Association of Maternal Asthma and Early Pregnancy Vitamin D with Risk of Preeclampsia: An Observation From Vitamin D Antenatal Asthma Reduction Trial (VDAART). J Allergy Clin Immunol Pract . 2018;6:600-608.e602. doi:10.1016/j.jaip.2017.07.018.
  18. O’Callaghan KM, Kiely M. Systematic Review of Vitamin D and Hypertensive Disorders of Pregnancy. Nutrients. 2018;10. doi:10.3390/nu10030294.
  19. Mäkinen M, Löyttyniemi E, Koskinen M, Vähä-Mäkilä M, Siljander H, Nurmio M, et al. Serum 25-Hydroxyvitamin D Concentrations at Birth in Children Screened for HLA-DQB1 Conferred Risk for Type 1 Diabetes.J Clin Endocrinol Metab . 2019;104:2277-2285. doi:10.1210/jc.2018-02094.
  20. Tapia G, Marild K, Dahl SR, Lund-Blix NA, Viken MK, Lie BA, et al. Maternal and Newborn Vitamin D-Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes.Diabetes Care . 2019;42:553-559. doi:10.2337/dc18-2176.
  21. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy Report. Obstet Gynecol.2013;122:1122-1131. doi:10.1097/01.AOG.0000437382.03963.88.
  22. Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study.Diabetes Care . 2009;32:2005-2009. doi:10.2337/dc09-0656.
  23. Bennett SE, McPeake J, McCance DR, Manderson JG, Johnston P, McGalliard R, et al. Maternal vitamin D status in type 1 diabetic pregnancy: impact on neonatal vitamin D status and association with maternal glycaemic control. PLoS One. 2013;8:e74068. doi:10.1371/journal.pone.0074068.
  24. Azar M, Basu A, Jenkins AJ, Nankervis AJ, Hanssen KF, Scholz H, et al. Serum carotenoids and fat-soluble vitamins in women with type 1 diabetes and preeclampsia: a longitudinal study. Diabetes Care . 2011;34:1258-1264. doi:10.2337/dc10-2145.
  25. Yu Y, Jenkins AJ, Nankervis AJ, Hanssen KF, Scholz H, Henriksen T, et al. Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women. Diabetologia . 2009;52:160-168. doi:10.1007/s00125-008-1182-x.
  26. Du M, Basu A, Fu D, Wu M, Centola M, Jenkins AJ, et al. Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care. 2013;36:2054-2061. doi:10.2337/dc12-1934.
  27. Basu A, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Henriksen T, et al. Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy. Nutr Res. 2015;35:421-430. doi:10.1016/j.nutres.2015.04.004.
  28. Kelly CB, Hookham MB, Yu JY, Lockhart SM, Du M, Jenkins AJ, et al. Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes. Diabetologia. 2017;60:2514-2524. doi:10.1007/s00125-017-4415-z.
  29. Kelly CB, Hookham MB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes.Diabetes Care . 2018;41:120-127. doi:10.2337/dc17-1635.
  30. Kelly CB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, et al. Haptoglobin phenotype modulates lipoprotein-associated risk for preeclampsia in women with Type 1 diabetes. J Clin Endocrinol Metab . 2019;104:4743-4755. doi:10.1210/jc.2019-00723.
  31. Bikle DD, Siiteri PK, Ryzen E, Haddad JG. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin. Endocrinol Metab. 1985;61:969-975. doi :10.1210/jcem-61-5-969
  32. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin. Endocrinol Metab. 1986;63:954-959. doi:10.1210/jcem-63-4-954
  33. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M. Vitamin D and DBP: The free hormone hypothesis revisited. J Steroid Biochem Mol Biol. 2014;144:132-137. doi:10.1016/j.jsbmb.2013.09.012.
  34. Schwartz JB, Lai J, Lizaola B, Kane L, Weyland P, Terrault NA, et al. Variability in free 25(OH) vitamin D levels in clinical populations.J Steroid Biochem Mol Biol. 2014;144 Pt A:156-158. doi:10.1016/j.jsbmb.2013.11.006.
  35. Yu C, Xue H, Wang L, Chen Q, Chen X, Zhang Y, et al. Serum Bioavailable and Free 25-Hydroxyvitamin D Levels, but Not Its Total Level, Are Associated With the Risk of Mortality in Patients With Coronary Artery Disease. Circ Res. 2018;123:996-1007. doi:10.1161/CIRCRESAHA.118.313558.
  36. Bhan I, Powe CE, Berg AH, Ankers E, Wenger JB, Karumanchi SA, et al. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int. 2012;82:84-89. doi:10.1038/ki.2012.19
  37. Karras SN, Polyzos SA, Newton DA, Wagner CL, Hollis BW, Ouweland JVD, et al. Adiponectin and vitamin D-binding protein are independently associated at birth in both mothers and neonates. Endocrine . 2018;59:164-174. 10.1007/s12020-017-1475-2
  38. Bikle DD, Gee E, Halloran B, Haddad JG. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest. 1984;74:1966-1971. doi: 10.1172/JCI111617
  39. Bouillon R. Chapter 5 - The Vitamin D Binding Protein DBP. In: Feldman D, Pike JW, Adams JS (eds) Vitamin D (Third Edition). Academic Press, San Diego, pp 57-72; 2011.
  40. Newton DA, Baatz JE, Kindy MS, Gattoni-Celli S, Shary JR, Hollis BW, et al. Vitamin D binding protein polymorphisms significantly impact vitamin D status in children. Pediatric Res.2019;86(5):662-669. doi:10.1038/s41390-019-0322-y.
  41. Hollis BW, Pittard WB, 3rd. Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences. J Clin Endocinol Metab. 1984;59:652-657. doi:10.1210/jcem-59-4-652
  42. Adams JS, Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys. 2012;523(1): 95-102. 10.1016/j.abb.2012.02.016
  43. Al-Badr W, Martin KJ. Vitamin D and kidney disease. Clin J Am Soc Nephrol. 2008;3:1555-1560. doi:10.2215/CJN.01150308.
  44. Kim CS, Kim SW. Vitamin D and chronic kidney disease. Korean J Intern Med. 2014;29:416-427. doi:10.3904/kjim.2014.29.4.416.
  45. Noyola-Martinez N, Diaz L, Avila E, Halhali A, Larrea F, Barrera D. Calcitriol downregulates TNF-alpha and IL-6 expression in cultured placental cells from preeclamptic women. Cytokine . 2013;61: 245-250. 10.1016/j.cyto.2012.10.001
  46. Olmos-Ortiz A, Noyola-Martinez N, Barrera D, Zaga-Clavellina V, Avila E, Halhali A, et al. IL-10 inhibits while calcitriol reestablishes placental antimicrobial peptides gene expression. J Steroid Biochem Mol Biol. 2015;148: 187-193. 10.1016/j.jsbmb.2014.07.012
  47. Tian X, Ma S, Wang Y, Hou L, Shi Y, Yoa M, et al. Effects of Placental Ischemia Are Attenuated by 1,25-Dihydroxyvitamin D Treatment and Associated with Reduced Apoptosis and Increased Autophagy. DNA Cell Biol 2016;35: 59-70. doi:10.1089/dna.2015.2885
  48. August P, Marcaccio B, Gertner JM, Druzin ML, Resnick LM, Laragh JH. Abnormal 1,25-dihydroxyvitamin D metabolism in preeclampsia. Am J Obstet Gynecol . 1992;166: 1295-1299. doi:10.1016/s0002-9378(11)90625-5
  49. Legarth C, Grimm D, Wehland M, Bauer J, Kruger M. The Impact of Vitamin D in the Treatment of Essential Hypertension. Int J Mol Sci. 2018;19. doi:10.3390/ijms19020455
  50. Corcoy R, Mendoza LC, Simmons D, Desoye G, Adelantado JM, Chico A, et al. The DALI vitamin D randomized controlled trial for gestational diabetes mellitus prevention: No major benefit shown besides vitamin D sufficiency. Clin Nutr. 2020;39: 976-984. 10.1016/j.clnu.2019.04.006